The FDA today announced plans for a workshop to discuss the development of technologies for detecting biomarkers related to traumatic brain injuries. The aim of the workshop is to discuss both the challenges and solutions related to biomarker development methodologies, the FDA said. During the meeting, the agency will seek to establish strategies for standardizing […]
Philips
Philips wins 510(k) for MR suite patient monitor system
Royal Philips (NYSE:PHG) said today it won FDA 510(k) clearance for its Expression MR400 monitor designed for patients undergoing magnetic resonance imaging. The MR400 is designed to provide ICU-comparable bedside monitoring for all patients, including those with serious medical conditions or those who require anesthesia, in the MR Suite. “When a patient is under anesthesia, […]
Philips, BTG tout 1st live-imaging embo bead procedure
Royal Philips (NYSE:PHG) and BTG said today the 1st patient has been treated by a live-image guided LC Bead Lumi in a treatment aiming to block blood flow to a hypervascular tumor in a patient with liver cancer. BTG’s LC Bead Lumis are embolic beads which can be visualized during interventional procedures to allow operating […]
Philips inks integrated health data deal with Validic
Royal Philips (NYSE:PHG) said it inked a deal with digital health tech company Validic that will allow Philips to integrate personal health data from 3rd-party devices and apps into its platform of cloud-based HealthSuite programs. The collaborative deal will help “expand the breadth and depth” of Philips health tech, including Personal Health Programs, Lifeline medical alert […]
Philips issues urgent safety notice for Allura systems
Royal Philips (NYSE:PHG) issued a set of field safety notices for its Allura Xper system, including the FD, Centron, Clarity and CV20 models over issues with failing alarms and unexpected system movements. The Integris Allura Xper system is designed for cardiovascular and vascular X-ray imaging applications as well as interventional procedures such as percutaneous transluminal coronary […]
Philips, looking to boost health biz, lures Airbus exec Botti
Royal Philips (NYSE:PHG) said today that it named former Airbus (EPA:AIR) executive Jean Botti as chief innovation & strategy officer, effective April 1, in a bid to grow its healthtech division. Botti, who’s slated to start at the Dutch conglomerate April 1, succeeds Jim Andrew, who stepped down for personal reasons last year, Philips said. Botti […]
Sales, profits rise for Philips Healthcare
Sales and profits for the healthcare division at Royal Philips (NYSE:PHG) rose for both the 4th quarter and full-year 2015. The Dutch conglomerate, which is looking to deal its legacy lighting business and its Lumileds LED operation, said Philips Healthcare reported sales growth of 14.8% to $3.54 billion (€3.27 billion) for the 3 months ended Dec. […]
UPDATE: Philips forced to spike Lumileds deal on U.S. security concerns
Updated with new information on the proposed sale. (Reuters) — Royal Philips‘s (NYSE:PHG) plan to shed its lighting businesses suffered a setback on Friday when a $3.3 billion deal to offload the components division to Asian buyers was blocked by the United States on security grounds. The agreement to sell an 80% stake in the Lumileds division […]
Philips launches mobile obstetrics monitor in Indonesia
Royal Philips (NYSE:PHG) said today it inked a deal with West Sumatra, Indonesia-based Sijunjung Regency to launch its Mobile Obstetrics Monitoring service in the region. The service is designed to identify expecting mother who are at risk of pregnancy related complications to help lower maternal mortality rates, and is smartphone-based and scaleable, Philips said. Philips […]
Philips inks $90m patient care deal with Marin General Hospital
Royal Philips (NYSE:PHG) said today it signed a 15-year, $90 million patient healthcare partnership with Marin General Hospital, which serves Marin County, just north of San Francisco. The agreement is the 1st of its kind for the hospital and the 3rd for Philips in North America over the last 6 months, the company said. “We […]
Philips and Banyan ink deal to dev handheld concussion test
Royal Philips (NYSE:PHG) and blood test developer Banyan Biomarkers said today they inked a deal to develop and commercialize a handheld blood test to test for concussions. Financial terms of the agreement were not disclosed. The new test will be based on Philips’ Minicare I-20 system, and will useable at the point of care, the […]